A Health Podyssey

The episode delivers concrete research findings with specific metrics (5% decline in RN minutes, 12% decline in social worker minutes, 27-58% declines in high-intensity care) and nuanced distinctions between PE and PTC acquisitions. However, there is moderate filler including lengthy introductions, thanks to co-authors, and repetitive framing that could have been condensed, reducing the insight-per-minute ratio.

“after the PE acquisition, registered nurse minutes per thirty days per beneficiary declined roughly 5%, social worker minutes declined 12%, and home hospice eight minutes declined 6%”

“reductions in care intensity were concentrated amongst certain large acquisitive platforms, rather than occurring constantly across all PE and PTC owned hospices”

The study makes a genuine methodological contribution (first to use claims-based data with quasi-experimental methods on this question) and the key finding - that effects vary by firm rather than being uniform - is counterintuitive and useful. However, the underlying frameworks (PE cost-cutting pressures, care intensity measures) are familiar from prior healthcare literature, and the guest doesn't introduce truly novel conceptual angles beyond the research itself.

“To our knowledge, before conducting this study, no studies have used the claim based data and the rigorous quasi experimental methods to examine the impact of PE and the PDC acquisitions on hospice care delivery”

“not all PE and the PDCA owned hospices are bad. So reductions in care intensity were concentrated amongst certain large acquisitive platforms”

Dr. Jiebing Wen is a research assistant professor with published work in Health Affairs, bringing legitimate academic credibility on the specific topic. However, she is early-career rather than a seasoned operator or executive, and the episode lacks a practitioner (e.g., a hospice director or former PE investor) who could speak to implementation and real-world dynamics beyond the data.

“Doctor. Jiebing Wen, a research assistant professor at the University of Texas at Austin College of Pharmacy”

“a new paper in the August issue of Health Affairs”

The episode is rich with concrete data points: specific percentages (25% of beneficiaries from PE/PTC hospices, 80% for-profit ownership, $26B Medicare spending), precise metric declines (5%, 12%, 6%, 9%, 27%, 58%), named data sources (Medicare Cost Reports, CAHPS Hospice Survey 2022, 2010-2021 timeframe), and acknowledgment of methodology limitations. This is substantially above average for B2B podcast specificity.

“By 2021, an estimate 25% of Medicare hospice beneficiaries received care from PE or PTC owned hospice agencies”

“in 2023, Medicare spent nearly $26,000,000,000 on hospice care for approximately 1,700,000 beneficiaries”

The host asks competent, structured questions that move logically through the research (context, findings, measurement, policy implications) and includes a clarifying follow-up on care intensity. However, questions are largely softball and agenda-driven rather than challenging; the host does not probe tensions, ask about counterarguments, or push back on any claims. No genuine productive disagreement occurs.

“Can you give us a sense of how widespread private equity as well as publicly traded corporations acquisition of hospice practices are these days?”

“can you say a little bit about sort of how you measure care intensity?”